Post-transplantation nephrotic syndrome

Kidney International

Volumn 69, Issue 6, 2006, Pages 1088-1091

  Stokes, M B ^a   De Palma, J ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b Rutgers Health Community Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TSUKUBAENOLIDE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; FEMALE; FOCAL GLOMERULONEPHRITIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPOALBUMINEMIA; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; VENOUS BLOOD;

BIOPSY; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MICROSCOPY, ELECTRON; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA; RECURRENCE;

EID: 33644861462     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000122     Document Type: Article

References (24)

1. Kim HC, Park SB, Lee SH et al. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance. Transplant Proc 1994; 26: 2134-2135.
2. Hohage H, Kleyer U, Bruckner D et al. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron 1997; 75: 160-165.
3. Yakupoglu U, Baranowska-Daca E, Rosen D et al. Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 2004; 65: 2360-2370.
4. Cheigh JS, Mouradian J, Susin M et al. Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course. Kidney Int 1980; 18: 358-365.
5. Colvin R. Renal Transplant Pathology. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney. Vol. 2. Lippincott-Raven: Philadelphia, 1998, pp. 1409-1540.
6. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2: S258-263.
7. Artero M, Biava C, Amend W et al. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-383.
8. Striegel JE, Sibley RK, Fryd DS, Mauer SM. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int Suppl 1986; 19: S44-50.
9. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883.
10. Feld SM, Figueroa P, Savin V et al. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 1998; 32: 230-237.
11. Cattran D, Neogi T, Sharma R et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 2003; 14: 448-453.
12. Hubsch H, Montane B, Abitbol C et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol 2005; 20: 210-216.
13. Cheong HI, Han HW, Park HW et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15: 78-81.
14. Verani RR, Hawkins EP. Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion. Am J Nephrol 1986; 6: 263-270.
15. Bariety J, Bruneval P, Hill G et al. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001; 12: 261-274.
16. Zafarmand AA, Baranowska-Daca E, Ly PD et al. De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature. Clin Transplant 2002; 16: 350-361.
17. Markowitz GS, Stemmer CL, Croker BP, D'Agati VD. De novo minimal change disease. Am J Kidney Dis 1998; 32: 508-513.
18. Ichikawa I, Fogo A. Focal segmental glomerulosclerosis. Pediatr Nephrol 1996; 10: 374-391.
19. Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990; 38: 115-123.
20. Kemeny E, Mihatsch MJ, Durmuller U, Gudat F. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis. Clin Nephrol 1995; 43: 71-83.
21. Matalon A, Markowitz GS, Joseph RE et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001; 56: 271-278.
22. Nishimura M, Toki J, Sugiura K et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 1994; 179: 1053-1058.
23. Savin VJ, McCarthy ET, Sharma M. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 147-160.
24. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.